QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$49.75−0.06 (-0.12%)
Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%
Qiagen gross margin
Gross margin is gross profit as a percentage of revenue.
For fiscal 2025 it was 62.2%, against 48.9% the year before. The highest annual figure on record is 67.2% in fiscal 2008.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 62.2% | +13.3 |
| FY2024 | Dec 31, 2024 | 48.9% | −13.9 |
| FY2023 | Dec 31, 2023 | 62.8% | −1.9 |
| FY2022 | Dec 31, 2022 | 64.7% | +0.2 |
| FY2021 | Dec 31, 2021 | 64.4% | −1.5 |
| FY2020 | Dec 31, 2020 | 65.9% | +0.1 |
| FY2019 | Dec 31, 2019 | 65.9% | −0.8 |
| FY2018 | Dec 31, 2018 | 66.6% | +1.6 |
| FY2017 | Dec 31, 2017 | 65.1% | +2.0 |
| FY2016 | Dec 31, 2016 | 63.1% | −1.4 |
| FY2015 | Dec 31, 2015 | 64.5% | +0.2 |
| FY2014 | Dec 31, 2014 | 64.3% | +1.7 |
| FY2013 | Dec 31, 2013 | 62.6% | −3.1 |
| FY2012 | Dec 31, 2012 | 65.7% | +1.6 |
| FY2011 | Dec 31, 2011 | 64.1% | −1.7 |
| FY2010 | Dec 31, 2010 | 65.8% | −0.3 |
| FY2009 | Dec 31, 2009 | 66.1% | −1.1 |
| FY2008 | Dec 31, 2008 | 67.2% | – |
See a number that looks wrong?